Efrat Katsman

Efrat Katsman

Auto-generated profile, based on publicly available information

Efrat Katsman

Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2022 in Genome Biology
Verified
Journal Article
Open access
PDF file
EKEfrat Katsman
Efrat Katsman
SOShari Orlanski
Shari Orlanski
FMFilippo Martignano
Filippo Martignano
IFIlana Fox-Fisher
Ilana Fox-Fisher
RSRuth Shemer
Ruth Shemer
BBBenjamin P. Berman
Benjamin P. Berman
The Oxford Nanopore (ONT) platform provides portable and rapid genome sequencing, and its ability to natively profile DNA methylation without complex sample processing is attractive for point-of-care real-time sequencing. We recently demonstrated ONT shallow whole-genome sequencing to detect copy number alterations (CNAs) from the circulating tumor DNA (ctDNA) of cancer patients. Here, we show that cell type and cancer-specific methylation changes can also be detected, as well as cancer-associated fragmentation signatures. This feasibility study suggests that ONT shallow WGS could be a powerful tool for liquid biopsy. Graphical Abstract

21 August 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
IUI. Unterman
I. Unterman
DAD. Avrahami
D. Avrahami
EKE. Katsman
E. Katsman
TTT.J. Triche
T.J. Triche
BGB. Glaser
B. Glaser
BBB.P. Berman
B.P. Berman
Background: Deconvolution is used to estimate the proportion of mixed cell types from tissue or blood samples based on genomic profiling. DNA methylation is commonly used because specific CpG positions reflect cell type identity and can be accurately measured at either the population or single-molecule level. Methylation sequencing techniques can profile multiple individual CpGs on a single DNA molecule, but few deconvolution models have been developed to exploit these single-molecule methylation haplotypes for cell type deconvolution. Results and Conclusions: We used simulated whole-genome methylation data and in silico mixtures of real data to compare existing deconvolution tools with two new models developed here. We found that adapting an existing model CelFiE to incorporate methylation haplotype information improved deconvolution accuracy by ∼30% over other tools, including the original CelFiE. In addition to overall higher accuracy, our new tool CelFiE Integrated Single-molecule Haplotypes (or CelFiE-ISH ) outperformed others in detecting rare cell types present at 0.1% and below. Detection of rare cell types is important for the analysis of circulating DNA, which we demonstrate using a patient-derived plasma sequencing dataset.Finally,we show that marker selection strategy has a strong effect on deconvolution accuracy, concluding that haplotype-aware deconvolution can take advantage of markers tailored for that purpose.

18 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
EKEfrat Katsman
Efrat Katsman
SISara Isaac
Sara Isaac
ADAlaa Darwish
Alaa Darwish
MMMyriam Maoz
Myriam Maoz
MIMichal Inbar
Michal Inbar
AEAmir Eden
Amir Eden
Liquid biopsy using ultra-low-pass whole-genome sequencing (ULP-WGS, ∼0.25x coverage) is a promising tool to detect circulating tumor DNA (ctDNA) for cancer management, and the use of the native Oxford Nanopore (ONT) sequencing platform adds DNA methylation to the set of detectable features. Here, we test the performance of methylation-based cell-type deconvolution in ULP-WGS samples from diverse epithelial malignancies and investigate several new computational strategies using our CelFiE-ISH deconvolution framework. We find that incorporating larger numbers of markers restricted to the epithelial cell lineage can reduce the cancer fraction limit of detection down to 1.7-3.1%, matching or exceeding the 3% floor of established copy-number alteration (CNA) benchmarks. Our study provides a useful strategy for analysis of ULP-WGS ONT data and indicates that marker selection remains a key challenge for analyzing methylation-based cancer datasets.

9 June 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
HMHagit Masika
Hagit Masika
SRShmuel Ruppo
Shmuel Ruppo
SCStephen J. Clark
Stephen J. Clark
MBMarc Jan Bonder
Marc Jan Bonder
FMFerdinand von Meyenn
Ferdinand von Meyenn
HCHoward Cedar
Howard Cedar
Aging is a complex multifactorial process that affects cellular function and tissue homeostasis over time. Despite substantial research, the molecular mechanisms driving cellular aging remain poorly understood. Many studies focused on changes in DNA methylation as an indicator of aging. In particular, methylation at polycomb CpG islands was shown to be predictive of phenotypic changes associated with aging. Since many age-related pathological processes are thought to originate from single cells, we asked whether polycomb CpG island methylation occurs preferentially in a subset of cells within a population. Using single-cell whole-genome methylation data across ages and tissues, we identify polycomb CpG methylation as a hallmark of cellular aging. This revealed that aging occurs at varying rates, with faster proliferating cells showing accelerated gain of methylation. Differential gene expression analysis identified changes in immune response, translation, tumorigenesis and neurodegeneration. These results challenge traditional models of homogeneous cellular aging and suggest that aging is a highly individualized process at the single-cell level, that may be driven by programmed changes in polycomb CpG island DNA methylation.

19 October 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
EKEfrat Katsman
Efrat Katsman
SOShari Orlanski
Shari Orlanski
FMFilippo Martignano
Filippo Martignano
IFIlana Fox-Fisher
Ilana Fox-Fisher
RSRuth Shemer
Ruth Shemer
BBBenjamin P. Berman
Benjamin P. Berman
The Oxford Nanopore (ONT) platform provides portable and rapid genome sequencing, and its ability to natively profile DNA methylation without complex sample processing is attractive for clinical sequencing. We recently demonstrated ONT shallow whole-genome sequencing to detect copy number alterations (CNA) from the circulating tumor DNA (ctDNA) of cancer patients. Here, we show that cell-type and cancer-specific methylation changes can also be detected, as well as cancer-associated fragmentation signatures. This feasibility study suggests that ONT shallow WGS could be a powerful tool for liquid biopsy, especially real-time medical applications.